We bring automated cell-monitoring solutions for cell & gene therapy, vaccine industry and life sciences applications. Our microscopes are easy-to-use, label-free and non-invasive tools for the three-dimensional, real-time imaging of living cells. Based on patented differential digital holography technology, our advanced systems generate reliable, high-quality holographic images providing highly-reproducible tracking of: - cell density - morphology - cell viability - viral infection kinetics - cell activation status Direct Benefits Our technology can benefit a range of applications, from R&D to manufacturing processes, and enable significant cost reduction and quality improvement. Our microscopes are particularly convenient and robust for automated cell culture monitoring, analysis and quality control.
Looking for a particular Ovizio employee's phone or email?
The Ovizio annual revenue was $1 million in 2026.
André Lebacq is the Vice President of Technology of Ovizio.
9 people are employed at Ovizio.
Ovizio is based in Bruxelles Uccle, Brussels Capital.
The NAICS codes for Ovizio are [541713, 541, 54171, 54, 5417].
The SIC codes for Ovizio are [87, 873].